This systematic review provides supporting evidence for a clinical practice guideline for the
management of rapid eye movement (REM) sleep behavior disorder in adults and children …

Parkinson's disease (PD) is a multisystem alpha-synucleinopathic neurodegenerative
disease and the most prevalent neurodegenerative disorder after Alzheimer's disease with a …

Deep brain stimulation of the subthalamic nucleus is an effective and established therapy for
patients with advanced Parkinson's disease improving quality of life, motor symptoms and …

Background Sleep dysfunction is disabling in people with Parkinson's disease and is linked
to worse motor and non-motor outcomes. Sleep-specific adaptive Deep Brain Stimulation …

Beta-band activity in the subthalamic local field potential (LFP) is correlated with Parkinson's
disease (PD) symptom severity and is the therapeutic target of deep brain stimulation (DBS) …

Sleep disturbances are among the most common nonmotor complications of Parkinson's
disease (PD), can present in prodromal stages, and progress with advancing disease. In …

Growing evidence from Alzheimer disease supports a potentially beneficial role of slow‐
wave sleep in neurodegeneration. However, the importance of slow‐wave sleep in …

Sleep and circadian alterations are amongst the very first symptoms experienced in
Parkinson's disease, and sleep alterations are present in the majority of patients with overt …

Sleep disorders are integral to Parkinson's disease (PD). Insomnia, an inability to maintain
stable sleep, affects most patients and is widely rated as one of the most debilitating facets of …

Importance Sleep-wake disorders are a common and debilitating nonmotor manifestation of
Parkinson disease (PD), but treatment options are scarce. Objective To determine whether …